SARS CoV-2 Reinfection Across a Spectrum of Immunological
States
Justine M. McKittrick1, Thomas W.
Burke2, Elizabeth Petzold2, Gregory
D. Sempowski3, Thomas N. Denny3,
Christopher R. Polage, Ephraim L. Tsalik2,4-5, and
Micah T. McClain2,4-5
1Duke University School of Medicine, Durham, NC, USA,2Center for Applied Genomics and Precision Medicine,
Duke University, Durham, NC, USA,3Duke Human Vaccine
Institute, Durham, NC, USA, 4Durham Veterans Affairs
Medical Center, Durham, NC, USA, 5Division of
Infectious Diseases, Duke University Medical Center, Durham, NC, USA
Key Words : COVID-19; SARS-CoV-2; reinfection; antibody;
immunity